Literature DB >> 35074470

Discordance in categorization of acute-on-chronic liver failure in the United Network for Organ Sharing database.

Brian P Lee1, Giuseppe Cullaro2, Aidan Vosooghi3, Frederick Yao2, Sarjukumar Panchal4, David S Goldberg5, Norah A Terrault3, Nadim Mahmud4.   

Abstract

BACKGROUND & AIMS: Studies regarding acute-on-chronic liver failure (ACLF) among liver transplant (LT) candidates from the United Network for Organ Sharing (UNOS) database are being used to inform LT policy changes worldwide. We assessed the validity of identifying ACLF in UNOS.
METHODS: We performed stratified random sampling among 3 US LT centers between 2013-2019 to obtain a representative patient sample across ACLF grades. We compared the concordance of ACLF classification by UNOS vs. blinded manual chart review, according to EASL-CLIF.
RESULTS: Among 481 sampled LT registrants, 250 (52%) had no ACLF, 75 (16%) had ACLF grade 1, 79 (16%) had ACLF grade 2, and 77 (16%) had ACLF grade 3 per UNOS categorization. Concordance of ACLF grade by UNOS vs. chart review was: 72%, 64%, 56%, and 64% for no ACLF, grade 1, grade 2, and grade 3, respectively, with an overall Cohen's kappa coefficient of 0.48 (95% CI 0.42-0.54). Absence of acute decompensation was the most common reason for overestimation, and discordant brain and respiratory failure categorization were the most common reasons for underestimation of ACLF by UNOS.
CONCLUSIONS: In this retrospective multi-center study, ACLF categorization by UNOS showed weak agreement with manual chart review. These findings are informative for ongoing allocation policy discussions, highlight the importance of prospective studies regarding ACLF in LT, and should encourage UNOS reform. LAY
SUMMARY: Acute-on-chronic-liver-failure (ACLF) is a specific and common form of liver failure associated with high death rates. Studies have been published using the United States transplant registry (UNOS) to identify and describe outcomes of transplant candidates and recipients with ACLF, and these data are driving policy changes for transplant allocation around the world, but nobody has shown whether these data are reliable. We found that UNOS was not categorizing ACLF in concordance or accurately when compared to chart review, which shows the need for UNOS reform and non-UNOS studies to appropriately inform policies regarding the transplantation of patients with ACLF.
Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACLF; UNOS; bias; concordance; misclassification

Mesh:

Year:  2022        PMID: 35074470      PMCID: PMC9018597          DOI: 10.1016/j.jhep.2021.12.040

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   30.083


  11 in total

1.  A confidence interval approach to sample size estimation for interobserver agreement studies with multiple raters and outcomes.

Authors:  Michael A Rotondi; Allan Donner
Journal:  J Clin Epidemiol       Date:  2012-05-04       Impact factor: 6.437

2.  Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.

Authors:  Vinay Sundaram; Rajiv Jalan; Joseph C Ahn; Michael R Charlton; David S Goldberg; Constantine J Karvellas; Mazen Noureddin; Robert J Wong
Journal:  J Hepatol       Date:  2018-04-28       Impact factor: 25.083

3.  Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.

Authors:  Vinay Sundaram; Rajiv Jalan; Tiffany Wu; Michael L Volk; Sumeet K Asrani; Andrew S Klein; Robert J Wong
Journal:  Gastroenterology       Date:  2018-12-18       Impact factor: 22.682

4.  Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.

Authors:  David W Crabb; Ramon Bataller; Naga P Chalasani; Patrick S Kamath; Michael Lucey; Philippe Mathurin; Craig McClain; Arthur McCullough; Mack C Mitchell; Timothy R Morgan; Laura Nagy; Svetlana Radaeva; Arun Sanyal; Vijay Shah; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2016-02-24       Impact factor: 22.682

5.  Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients.

Authors:  Vinay Sundaram; Parth Shah; Robert J Wong; Constantine J Karvellas; Brett E Fortune; Nadim Mahmud; Alexander Kuo; Rajiv Jalan
Journal:  Hepatology       Date:  2019-05-17       Impact factor: 17.425

6.  Waitlist Priority for Patients with Acute-on-Chronic Liver Failure: Not Just Horseplay.

Authors:  Vinay Sundaram; Rajiv Jalan
Journal:  Liver Transpl       Date:  2021-11-11       Impact factor: 5.799

7.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

8.  Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS).

Authors:  Luca S Belli; Christophe Duvoux; Thierry Artzner; William Bernal; Sara Conti; Paolo A Cortesi; Sophie-Caroline Sacleux; George-Philippe Pageaux; Sylvie Radenne; Jonel Trebicka; Javier Fernandez; Giovanni Perricone; Salvatore Piano; Silvio Nadalin; Maria C Morelli; Silvia Martini; Wojciech G Polak; Krzysztof Zieniewicz; Christian Toso; Marina Berenguer; Claudia Iegri; Federica Invernizzi; Riccardo Volpes; Vincent Karam; René Adam; François Faitot; Liane Rabinovich; Faouzi Saliba; Lucy Meunier; Mickael Lesurtel; Frank E Uschner; Costantino Fondevila; Baptiste Michard; Audrey Coilly; Magdalena Meszaros; Domitille Poinsot; Andreas Schnitzbauer; Luciano G De Carlis; Roberto Fumagalli; Paolo Angeli; Vincente Arroyo; Rajiv Jalan
Journal:  J Hepatol       Date:  2021-05-02       Impact factor: 25.083

9.  Interrater reliability: the kappa statistic.

Authors:  Mary L McHugh
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.